Skip to main content
Orexo AB (publ) (STO:ORX)
Sweden flag Sweden · Delayed Price · Currency is SEK
25.00
-0.40 (-1.57%)
Mar 9, 2026, 5:29 PM CET

Orexo AB Revenue

In the year 2025, Orexo AB had annual revenue of 26.00M SEK, down -95.59%. Orexo AB had revenue of 3.30M in the quarter ending December 31, 2025, a decrease of -97.94%.

Revenue
26.00M
Revenue Growth
-95.59%
P/S Ratio
34.32
Revenue / Employee
361.11K
Employees
72
Market Cap
892.23M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202526.00M-564.00M-95.59%
Dec 31, 2024590.00M-48.80M-7.64%
Dec 31, 2023638.80M14.50M2.32%
Dec 31, 2022624.30M59.30M10.50%
Dec 31, 2021565.00M-98.60M-14.86%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cinclus Pharma Holding AB 57.47M
Nanexa AB 55.94M
Dicot Pharma AB 200.00K
Enzymatica AB 53.90M
Moberg Pharma AB 13.54M
EQL Pharma AB 425.75M
Cereno Scientific AB 44.27M
Klaria Pharma Holding AB (publ.) 8.99M
Revenue Rankings

Orexo AB News

More News